IP Library Granted Patent US 9,822,405
Granted Patent B2
US 9,822,405 · App. 14/752,396 · Granted Nov 21, 2017

Multiplex amplification of polynucleotides

Inventors: Mark Andersen (Carlsbad, CA); David Ruff (San Francisco, CA)
Assignee: APPLIED BIOSYSTEMS, LLC
C12Q1/686C12Q1/6806C12Q1/6827C12Q1/6851
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,822,405
App. No.
14/752,396
Granted
Nov 21, 2017
Kind
B2
Abstract

The present invention provides methods, reagents and kits for carrying out a variety of assays suitable for analyzing polynucleotides or samples that include an amplification step performed in a multiplex fashion. Also provided are methods for analyzing and improving the efficiency of amplification and for carrying out gene expression analysis.

Claims (19)

1. A method of generating a plurality of target sequences of interest, comprising the step of:

amplifying one or more target polynucleotides in the presence of a plurality of amplification primers suitable for amplifying a plurality of target sequences of interest and in the presence of a plurality of labeled oligonucleotide probes,

wherein each of the plurality of labeled oligonucleotide probes is complementary to a region of an amplified target sequence of interest and has the same label suitable for monitoring amplification as a function of time.

2. The method of claim 1 in which the product of the amplification is further subjected to at least one assay selected from the group consisting of single polynucleotide polymorphism analysis, genotyping analysis, gene expression analysis, fingerprinting analysis, analysis of gene mutations for genetic diagnoses, analysis of rare expressed genes in cells, nucleic acid sequencing, nucleic acid mini-sequencing and gene expression analysis.

3. The method of claim 1 in which the product of the amplification is further subjected to at least one assay selected from the group consisting of chromatography, electrophoresis, and staining with a dye or hybridization probe.

4. The method of claim 1 in which the product of the amplification is divided into a plurality of aliquots.

5. The method of claim 2 in which the product of the amplification is divided into a plurality of aliquots and wherein said at least one assay is performed on at least one of said aliquots.

6. The method of claim 5 wherein the number of aliquots is equal to the number of primer pairs used in said amplifying.

7. The method of claim 1 in which the amplification is carried out in the presence of uracil N-glycosylase.

8. The method of claim 1 wherein the one or more target polynucleotides is a plurality of target polynucleotides.

9. The method of claim 1 wherein the one or more target polynucleotides comprise a cDNA library.

10. The method of claim 1 wherein the amplifying is achieved with a thermostable DNA polymerase.

11. The method of claim 1 wherein the plurality of labeled oligonucleotides probes is selected from the group consisting of 5 ′-exonuclease probes, stem-loop beacon probes, and stemless beacon probes.

12. The method of claim 1 wherein the label is a fluorophore.

13. The method of claim 1 wherein the amplifying is by a polymerase chain reaction carried out for a number of cycles such that the amplification remains in the linear range.

14. The method of claim 1 wherein the amplifying comprises 10 to 20 polymerase chain reaction cycles.

15. The method of claim 1 wherein the amplifying comprises 2 to 14 polymerase chain reaction cycles.

16. The method of claim 1 wherein at least 50% of the amplification primers are present at concentrations in the range from 30 nM to 100 nM for each primer.

17. The method of claim 1 wherein at least 50% of the amplification primers are present at approximately equimolar concentration from 30 nM to 100 nM for each primer.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2017
From: ANDERSEN, MARK R.; RUFF, DAVID W.
To: APPLERA CORPORATION
Reel/Frame 043745/0907 →
CHANGE OF NAME Recorded Sep 29, 2017
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 043746/0043 →
MERGER Recorded Sep 29, 2017
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 043746/0110 →
Continuity (5)
Continuation 13645264 · Oct 4, 2012
Continuation 10723520 · Nov 26, 2003
Provisional Application 60525284 · Nov 25, 2003
Provisional Application 60431156 · Dec 4, 2002
Related Publication 20150292002A1 · Oct 15, 2015